The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic...
The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
About this item
Full title
Author / Creator
Kamp, Caroline Barkholt , Petersen, Johanne Juul , Faltermeier, Pascal , Juul, Sophie , Sillassen, Christina Dam Bjerregaard , Siddiqui, Faiza , Andersen, Rebecca Kjaer , Moncrieff, Joanna , Horowitz, Mark Abie , Hengartner, Michael Pascal , Kirsch, Irving , Gluud, Christian and Jakobsen, Janus Christian
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Mirtazapine is used to treat depression worldwide, and the effects of mirtazapine on depression rating scales are well-known. Our primary objective was to assess the risks of adverse events with mirtazapine for major depressive disorder.
We searched relevant sources from inception to 7 March 2024 for randomised clinical trials comparing mirtazap...
Alternative Titles
Full title
The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7060e735e1064c4e952950a32528c975
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7060e735e1064c4e952950a32528c975
Other Identifiers
ISSN
1471-244X
E-ISSN
1471-244X
DOI
10.1186/s12888-024-06396-6
